Information Provided By:
Fly News Breaks for May 6, 2019
May 6, 2019 | 07:07 EDT
Pivotal Research analyst Timothy Ramey downgraded Balchem to Hold from Buy following what he called a "tough quarter with poor sales performance across the board." While he believes the company is well-managed, he notes that Balchem is exposed to higher input costs and Ramey views the shares as fairly valued given that he sees Q1 being the start of "a weak year." He maintains a $100 price target on Balchem shares.
News For BCPC From the Last 2 Days
There are no results for your query BCPC